Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure.

Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure. Abstract Text:

David Wood,Jin-Ho Shin,Bernard Duval,Heinz-Joe Schmitt,

The potential of human papillomavirus (HPV) vaccines will only be realized if the vaccine candidates under development prove to be safe and effective and can be consistently produced to define quality standards. Whilst the responsibility for delivering a safe and effective product rests with the vaccine producer, a vaccine requires a license to allow it to be placed on the market. Licensure is based on an evaluation of the safety and efficacy profile of a vaccine candidate by national regulatory authorities, ideally on the basis of internationally agreed, science-based specifications and procedures. For vaccines, these international specifications are developed by the World Health Organization (WHO). The scientific basis for the regulatory evaluation of the safety and efficacy of HPV vaccines is described in this paper. Once a vaccine is licensed, a second set of criteria are evaluated by a different group of experts to provide advice to national health policy decision makers as to whether the vaccine should be introduced into national immunization programmes. Factors, such as evidence of high disease burden and high cost-effectiveness are taken into account in this second decision-making process.

Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure. Publishing Authors By Initials

D Wood,JH Shin,B Duval,HJ Schmitt,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Vaccine

VOLUME: 24 Suppl 3

Page Numbers: S187-92

Journal Abbreviation:

ISSN: 0264-410X

DAY: 12

MONTH: 06

YEAR: 2006

Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8406899

Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure.

AFFILIATION: World Health Organization, Immunizations, Vaccines and Biological, Avenue Appia, CH 1211 Geneva, Switzerland.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Vaccine

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure Related Publications

• ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.
• Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials.
• Biomechanical and immunohistochemical analysis of high hydrostatic pressure-treated Achilles tendons.
• Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: The scientific basis of regulatory expectations pre- and post-licensure.
• Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease.
• Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.
• Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.
• Effects of carrageenan and morphine on acute inflammation and pain in Lewis and Fischer rats.
• Effects of porcine bile on survival of Bacillus cereus vegetative cells and Haemolysin BL enterotoxin production in reconstituted human small intestine media.
• Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.
• Estimating the onset of cambial activity in Scots pine in northern Finland by means of the heat-sum approach.
• Force plate for measuring the ground reaction forces in small animal locomotion.
• Forelimb and hindlimb forces in walking and galloping primates.
• FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
• Gynecological cytology: too old to be a pop star but too young to die.
• Hearing aid device that can be worn in the ear with a housing.
• Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.
• Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
• Immunohistochemical expression of VEGF-A and its ligands in non-neoplastic lesions of the breast sampling-assisted by dynamic angiothermography.
• Lymphatic vessel density and epithelial D2-40 immunoreactivity in pre-invasive and invasive lesions of the uterine cervix.
• Methodological issues in the assessment of substance use phenotypes.
• Prediction of lung cancer using volatile biomarkers in breath.
• Protection-based assays to measure aminoacyl-tRNA binding to translation initiation factors.
• Regulatory T cells--the renaissance of the suppressor T cells.
• Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment.
• The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
• The association of pregnancy and the development of obesity - results of a systematic review and meta-analysis on the natural history of postpartum weight retention.
• The binding of advanced glycation end products to cell surfaces can be measured using bead-reconstituted cellular membrane proteins.
• The evolution of asymmetric genitalia in spiders and insects.
• [Cardiac imaging in clinical electrophysiology]